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Identifying protein–protein interactions in 
somatic hypermutation
 
Myron F. Goodman and Matthew D. Scharff
 
Somatic hypermutation (SHM) in immunoglobulin genes is required for high 
affinity antibody–antigen binding. Cultured cell systems, mouse model 
systems, and human genetic deficiencies have been the key players in 
identifying likely SHM pathways, whereas “pure” biochemical approaches have 
been far less prominent, but change appears imminent. Here we comment on 
how, when, and why biochemistry is likely to emerge from the shadows and 
into the spotlight to elucidate how the somatic mutation of antibody variable 
(
 
V
 
) regions is generated.
 
Wilson et al. (1) report in this issue
that the error-prone DNA polymerase
 
 
 
 is stimulated by the heterodimeric
MSH2–MSH6 mismatch repair recog-
nition complex. Humans deficient for
polymerase (pol)
 
 
 
 
 
 (2) or mice defi-
cient in MSH2–MSH6 (3–6) show a
significant reduction in hypermutation
at A:T sites. This study, which shows
a functional interaction between er-
ror-prone pol 
 
 
 
 and MSH2–MSH6, sug-
gests  that this low fidelity polymerase
might be working hand-in-hand with
the mismatch repair proteins to gener-
ate A:T mutations. At the very least,
these data provide an impetus for more
extensive biochemical analysis.
 
Properties and pathways of SHM
 
SHM is characterized by specific types
of base substitutions in the variable por-
tion of immunoglobulin genes which
occur at a million-fold higher fre-
quency than normal somatic mutations
(10
 
 
 
3
 
/bp versus 10
 
 
 
9
 
/bp). 
 
V
 
 region mu-
tations at G:C and A:T sites occur on
both strands of DNA in vivo. Mutations
at G:C sites tend to be favored in DNA
WRC hot spot motifs (WR: W 
 
 
 
 A or
T, R 
 
 
 
 purine). These mutations are
attributable to the C 
 
→
 
 U deamination
specificity of activation-induced cyti-
dine deaminase (AID; reference 7) acting
either on single-stranded DNA (ssDNA)
or on the nontranscribed strand within
a moving transcription bubble (7–9).
Mutations at A:T sites show a preference
for WA hot spot motifs reminiscent of
the in vitro behavior of pol 
 
 
 
. Pol 
 
 
 
 is
highly error prone and tends to generate
AT 
 
→
 
 GC mutations preferentially in
TA motifs in vitro (10). The expression
of AID, which occurs during a short
time span in B cells, is essential for
SHM as is active transcription of the 
 
V
 
gene (11, 12). In fact, biochemical studies
with semipurified AID provided the evi-
dence that ssDNA was the substrate for
AID, thus explaining the perplexing need
for transcription (7–9, 13).
A synopsis of potential SHM path-
ways responsible for the 
 
V
 
 region muta-
tions is shown in Fig. 1. C 
 
→
 
 T muta-
tions might be initiated by AID tracking
along a moving transcription bubble
and generating U residues on the non-
transcribed DNA strand or, less often,
on the transcribed DNA strand (7–9).
Faithful copying of U by a high fidelity
polymerase, such as pol 
 
 
 
 or pol 
 
 
 
, would
generate C to T transitions, whereas
aberrant copying of U by a low fidelity
polymerase, such as pol 
 
 
 
, could cause
both transitions (the replacement of a
purine with a different purine and pyri-
midine with a different pyrimidine) and
transversions (the replacement of a purine
with a pyrimidine or vice versa) (Fig. 1,
left). However, this simplified picture
cannot account for the equal numbers
of mutations at C on the transcribed
strand, nor can it explain mutations at
A:T sites.
Further SHM diversity could arise
if the U residue created by AID is excised
rather than copied. The removal of U
residues by the enzyme uracil 
 
N
 
-glyco-
sylase (UNG) results in an abasic site that
can then be removed by base excision
repair. Alternatively, a mismatched U:G
base pair can be repaired by mismatch
repair. In this process, single base mis-
matches are recognized by an MSH2–
MSH6 dimer which then recruits other
proteins to excise the mismatch and re-
place the excised DNA. In either case,
the repair patches—short in the case of
base excision repair and much longer in
the case of mismatch repair—would ex-
pose the transcribed strand to the action
of pol 
 
 
 
 to generate mutations at A:T
sites (Fig. 1, right). AID might also attack
C residues on the transcribed strand.
 
Biochemical issues and challenges
 
The “holy grail” from a biochemical
perspective would be to reconstitute
SHM entirely in a cell-free system using
purified proteins. This possibility might
not be all that remote given the avail-
ability of eukaryotic base excision repair,
mismatch repair, and RNA pol II tran-
scription systems in vitro. However,
defining where pol 
 
 
 
 and AID might
fit into any one of these systems is itself
a difficult problem, and full reconstitu-
tion of SHM would appear to require
integration of all of the components of
the base excision repair, mismatch repair,
and transcription systems—a daunting
task. The reconstitution of the system is
further complicated by the finding that
deletions and mutations of the COOH-
terminal end of AID result in the loss
of class switch recombination (which
requires AID-induced mutations in
switch regions upstream from the con-
stant regions, double-stranded DNA
breaks, and recombination), but the pres-
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ervation of 
 
V
 
 region SHM (14, 15),
whereas mutations at the NH
 
2
 
-terminal
end of AID affect SHM but not class
switch recombination (16). This sug-
gested that proteins such as RNA pol II
and replication protein A, which inter-
act with AID (17, 18), and possibly
other unidentified proteins, are re-
quired for the selective targeting of
AID to certain parts of the immuno-
globulin gene. A sensible point of de-
parture, therefore, would be to take a
step back and investigate individual
protein–protein and protein–nucleic acid
interactions.
 
MSH2–MSH6 stimulates pol 
 
 
 
 activity
 
The paper by Wilson et al. (1) identi-
fies a potentially relevant functional in-
teraction between MSH2–MSH6 and
pol 
 
 
 
, proteins that have been shown
to be involved in SHM diversification
(Fig. 1, right). The authors show that
endogenous MSH2 binds to pol 
 
 
 
 in
cell extracts, and that MSH2–MSH6
binds U:G mismatched base pairs, as
has also been noted previously (19).
The principal observation, however, is
that the rate of pol 
 
 
 
–catalyzed DNA
synthesis is increased 2.4-fold in the
presence of MSH2–MSH6. This in-
crease reflects an enhancement in the
catalytic efficiency (V
 
max
 
/K
 
m
 
) of pol 
 
 
 
with no discernible change in poly-
merase processivity. Control experi-
ments showed that DNA synthesis was
unaffected in the presence of MSH2–
MSH3 which recognizes larger mis-
matches, nor did MSH2–MSH6 stimu-
late pol 
 
 
 
, an error-prone polymerase
of unknown function. Admittedly, al-
though the increase in DNA synthesis
is a modest 2.4-fold, it nonetheless may
imply a coupling of mismatch repair
and DNA synthetic functions—which
could not be established solely by de-
tecting protein–protein binding inter-
actions using analyses such as chroma-
tin immunoprecipitation.
A possible coupling of error-prone
DNA synthesis with mismatch repair
should be viewed in the broader con-
text of determining the temporal fate of
a U:G base misrepair. MSH2–MSH6
can bind to U:G (19) (Fig. 1, right),
but competition for access to the U
residue might also include high and
low fidelity DNA polymerases vying
with proteins involved in base excision
repair. Each process, depending on
when it occurs, could leave its own
mutagenic signature. Because a heavy
enzymatic traffic jam is likely to con-
verge at the U residue once AID has
acted, the hypermutagenic outcome
depends on the enzyme queue. Do
replication and repair enzymes encoun-
ter U residues in a temporally ordered
process or in a random manner gov-
erned by mass action?
A recent paper by Rada et al. (20)
addresses the temporal access to U by
analyzing SHM and class switch re-
combination in mice deficient for both
mismatch repair and base excision re-
pair machinery. The data showed that
A:T hypermutation in immunoglobu-
lin 
 
V
 
 regions was eliminated entirely in
mice lacking both MSH2 and UNG. It
had been shown previously that the
elimination of either mismatch repair
(MSH2
 
 
 
/
 
 
 
) or base excision repair
(UNG
 
 
 
/
 
 
 
) caused a reduction in muta-
tions at A:T sites, with the loss of mis-
match repair having a far greater effect
(4, 21). It was concluded from that
study that mismatch repair is primarily
responsible for SHM at A:T sites with
base excision repair used as a backup
pathway (20). This suggests that AID-
generated U residues do lead to a pro-
cess in which MSH2–MSH6 competes
with UNG for access to the U residue
(Fig. 1, right).
Studies using the 
 
Msh2
 
 
 
/
 
 
 
 Ung
 
 
 
/
 
 
 
double knock-out mice nicely defined
the biochemical realities in vivo by, for
example, eliminating a role for uracil
Figure 1. AID-initiated SHM pathways. AID acting on ssDNA exposed in the transcription bubble 
in an immunoglobulin V region deaminates C preferentially at WRC hot spot motifs. Subsequent 
copying of U by a high-fidelity DNA polymerase results in C → T transitions, or copying by error-
prone pol   could generate C → N transition or transversion mutations. A second stage of diversifi-
cation leading to mutations at A:T sites requires the action of either mismatch repair proteins, includ-
ing MSH2–MSH6, or base excision repair proteins, including UNG and apurinic endonuclease (APE). 
Mutations at WA hot spot motifs could be made by pol   during long (mismatch repair) or short 
(base excision repair) gap-filling synthesis. The mismatch repair pathway (solid arrow) has been sug-
gested to play a greater role than the base excision repair pathway (dashed arrow) in introducing muta-
tions at A:T sites (20), although the relative importance of each pathway remains to be determined.
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DNA glycosylases other than UNG and
focusing our attention on the origins of
A:T mutation (20). However, many
questions cannot be addressed in vivo,
in short-term culture, or in cell lines
because molecules such as proliferating
cell nuclear antigen and RNA pol II are
critical for all cell processes. For exam-
ple, a possible queuing mechanism di-
recting protein access to U:G might
involve the proliferating cell nuclear
antigen. Along with its role in increas-
ing the processivity of pol 
 
 
 
 during
DNA replication, proliferating cell nu-
clear antigen is known to bind pol 
 
 
 
(22) and is required for mismatch repair
(23). It is possible that proliferating cell
nuclear antigen facilitates binding of pol
 
 
 
 with MSH2–MSH6 proximal to a
U:G mismatch, thus coordinating the
initiation of MMR with subsequent er-
ror-prone gap-filling synthesis. Now that
we have learned that MSH2–MSH6
appears to stimulate pol 
 
 
 
 activity di-
rectly (1), we can begin to imagine how
pol 
 
 
 
 might be selectively recruited to
generate mutations at A:T sites as part
of the mismatch repair machinery.
 
Help from biochemistry
 
A biochemical approach to reconstitute
SHM using purified proteins should
help us to advance beyond speculating
on the molecular mechanisms. It might
also make it possible to address the dif-
ferences that govern the targeting of
each of the repair mechanisms to 
 
V
 
 and
switch region, since the different DNA
substrates that characterize these re-
gions could be used.
An attempt to model G:C and
A:T hypermutation raises different
questions and engenders different chal-
lenges. If we assume that both muta-
tional processes originate from the ac-
tion of AID on ssDNA, perhaps by
tracking along the nontranscribed strand
of a transcription bubble, as suggested
from in vitro experiments using a bacte-
rial T7 transcription assay (7–9), then
how do mutations originate at the same
frequency at C sites on the transcribed
strand in vivo (24)? The chance that
AID might attack a transcribed strand
gap during mismatch repair or base
excision repair seems unlikely because
 
Msh2
 
 
 
/
 
 
 
Ung
 
 
 
/
 
 
 
 mutant and normal
mice show a similar distribution of
G:C-targeted mutations, except for the
absence of transversions in mutant mice,
which is presumably caused by the ab-
sence of UNG-generated abasic lesions
(20). Instead the mammalian RNA pol
II transcription apparatus, in contrast to
T7, may provide greater access to the
transcribed strand.
Thus, a mechanistic understanding
of G:C and A:T hypermutation would
benefit from studying AID in a mam-
malian transcription system for G:C
mutations, and by studying pol 
 
 
 
 in
conjunction with MSH2–MSH6-based
mismatch repair for A:T mutations.
The rationale for splitting the two
classes of mutations into two distinct
systems is based on the mouse data
showing that 
 
Msh2
 
 
 
/
 
 
 
Ung
 
 
 
/
 
 
 
 mice ap-
pear to mutate G:C but not A:T sites
(20). However, if AID acting on ss-
DNA during transcription is respon-
sible for triggering SHM (and class
switch recombination), then what is
responsible for confining these muta-
tions to immunoglobulin 
 
V
 
 regions?
Perhaps specialized transcription factors
or chromatin accessibility restrict the
targeting of AID to Ig
 
V
 
 genes.
A biochemical approach may also
help in resolving several extant contro-
versies. One involves the possibility that
AID may be acting on RNA in vivo,
not on DNA (25). A second posits that
antibody gene diversification requires
the presence of UNG during class
switch recombination, not for its ability
to excise U, but rather to stabilize a
protein complex needed for the muta-
tional process (26). Arguments for (27)
and against (28) this hypothesis have re-
cently appeared in the literature. A third
controversy involves the suggestion that
endonuclease-catalyzed blunt end dou-
ble-stranded DNA breaks, not AID, are
responsible for initiating SHM (29, 30).
It would seem that the burden of proof
in each of these examples rests on
showing that AID can use RNA as a
substrate, that catalytically inactive
UNG is an essential subunit of a com-
plex whose activity is currently un-
known, and that an endonuclease can
be identified having a specificity com-
mensurate with the properties of class
switching and mutagenesis.
As a means of addressing the target-
ing and trafficking of mutator proteins
to immunoglobulin 
 
V
 
 but not 
 
C
 
 re-
gions, and in investigating why one
repair pathway or error-prone poly-
merase is chosen in preference to
another, biochemistry should play a
decisive role in deciphering the mecha-
nisms of antibody diversification. To
paraphrase Arthur Kornberg (31), we
cannot be fully confident in our funda-
mental understanding of somatic hy-
permutation until the process has been
reconstituted successfully using purified
proteins with the ultimate goal to “cap-
ture it alive.”
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